Atossa Genetics News

1,38 $ 0,00% +0,00 $
In : 1,2487 € | 17:49:50 Uhr Nasdaq | Mehr Kurse »
WKN: A2JJ99
ISIN: US04962H5063
US-Symbol: ATOS
Typ: Aktie

Atossa Genetics News

  
15.10.19 Interview With Atossa Genetics Founder & CEO Steven Quay MD, Ph.D. Over Gynecomastia ACCESSWIRE
27.06.19 Thinking about buying stock in Aileron Therapeutics, Atossa Genetics, NVIDIA, Seelos Therapeutics, or Xpresspa? PR Newswire
24.04.19 Thinking about buying stock in Aurora Cannabis Inc., Akari Therapeutics, Atossa Genetics Inc., Boeing Co., or Reebonz Holding Ltd.? PR Newswire
15.03.19 Thinking about buying stock in Atossa Genetics Inc., Canopy Growth Corp., Facebook Inc., Micron Technology Inc., or Oxbridge Holdings? PR Newswire
10.01.19 Thinking about buying stock in American Airlines, Aurora Cannabis Inc, Atossa Genetics, Chesapeake Energy or Tilray? PR Newswire
04.12.18 Thinking about buying stock in Atossa Genetics, Cronos Group, New Age Beverages Co, Tesaro Inc. or 22nd Century Group Inc.? PR Newswire
04.03.16 OncoGenex: Der nächste Biotech-​Highflyer ist gestartet! sharedeals.de
02.03.16 Atossa Genetics: Jetzt rollen die News! sharedeals.de
26.02.16 Die Gerüchteküche brodelt: Biodel mit 0,58$ Cash je Aktie! sharedeals.de
22.02.16 Paion: Kursziel 5 Euro? Schauen Sie über den Tellerrand! sharedeals.de
19.02.16 Biotech-​Roundup: Sirona Biochem, Paion, Atossa Genetics, Biodel sharedeals.de
18.02.16 Atossa Genetics blüht auf: Was tun nach 200%? sharedeals.de
15.02.16 Aktien-​Roundup: Paion, Singulus, Atossa und griechische Banken sharedeals.de
12.02.16 Paion-​Alternative springt an – weitere Kurs­gewinne voraus! sharedeals.de
01.02.16 Atossa Genetics: Diesen Monat geht es los! sharedeals.de
22.01.16 Atossa Genetics: Insiderkäufe läuten Kurswende ein sharedeals.de
17.12.15 Atossa: Brustkrebs-​Spezialist vor explosiver Trendumkehr! sharedeals.de
09.11.15 Atossa Genetics: Exzellente Tradingchance vor den Zahlen sharedeals.de
06.08.15 Atossa Genetics and AAIPharma / Cambridge Major Laboratories Announce Manufacturing Agreement For Atossa's Lead Drug Candidate Afimoxifene Gel PR Newswire
06.08.15 Atossa Genetics and AAIPharma / Cambridge Major Laboratories Announce Manufacturing Agreement For Atossa's Lead Drug Candidate Afimoxifene Gel PR Newswire
22.11.13 SHAREHOLDER ALERT: Pomerantz Law Firm has filed a Class Action Against Atossa Genetics, Inc. and Certain Officers - ATOS PR Newswire
23.10.13 Top Trial Firm, Cohen, Placitella & Roth, PC, Investigating Atossa Genetics, Inc, for FDA Warning Letter and Product Recall PR Newswire
17.10.13 Bernstein Liebhard LLP Announces That A Class Action Has Been Filed Against Atossa Genetics, Inc. PR Newswire
14.10.13 Atossa Genetics, Inc. Sued by Investors After Stock Drops 46% on Drug Recall PR Newswire
12.10.13 Lifshitz Law Firm Announces Investigation of Atossa Genetics, Inc., Francesca's Holdings Corporation, Greenway Medical Technologies, Inc., and PVR Partners, L.P. PR Newswire
09.10.13 Harwood Feffer LLP Announces Investigation of Atossa Genetics, Inc. PR Newswire
08.10.13 Block & Leviton LLP Investigates Atossa Genetics, Inc. for Possible Violations of the Federal Securities Laws PR Newswire
07.10.13 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Atossa Genetics, Inc. - ATOS PR Newswire
07.10.13 Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Atossa Genetics, Inc. PR Newswire
17.05.13 Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference PR Newswire
02.05.13 Millennium HealthCare Signs Distribution Agreement with Atossa Genetics PR Newswire

Newssuche

  

Videos

  
15:33 Uhr 0,00%
JD.com, Baozun, Sea, Grubhub, Amazon, Microsoft, Nvidia, Nike, Aurora Cannabis, Lyft - US-Markt